ALDER BIOPHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$147.8M

711 transactions

Summary

ALDER BIOPHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $17.8MSales: $105.5M52 insiders

Date	Insider	Type	Value
2019-10-22	H LUNDBECK A S	J	—
2019-10-22	H LUNDBECK A S	J	—
2019-10-22	H LUNDBECK A S	Buy	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	U	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	J	$0
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	X	$0
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	X	$0
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	D	$0
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	U	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	D	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	D	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	D	—
2019-10-22	Joint reporting: Redmile Group, LLC; Green Jeremy	U	—
2019-10-22	Azelby Robert(President and CEO)	D	$0
2019-10-22	Azelby Robert(President and CEO)	D	$0
2019-10-22	Azelby Robert(President and CEO)	D	$0
2019-10-22	Azelby Robert(President and CEO)	D	$0
2019-10-22	Carter Paul Rutherford	D	$0
2019-10-22	Carter Paul Rutherford	D	$0
2019-10-22	Carter Paul Rutherford	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ALDER BIOPHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope